Zomedica Redefines Point of Care Diagnostics with TRUFORMA Biosensor Platform
If you’re a horse owner or veterinarian, you’re probably familiar with the challenges of diagnosing and treating equine health issues. Traditional diagnostic methods often require sending samples off to a lab and waiting days for results, causing delays in treatment and added stress for both the horse and owner. However, Zomedica Corp. is changing the game with their TRUFORMA biosensor platform.
A Game-Changer in Equine Health
Zomedica has been making waves in the veterinary health industry with their innovative point-of-care diagnostics and therapeutic devices for equine and companion animals. Their latest update to the TRUFORMA biosensor platform, the endogenous ACTH (eACTH) assay for equine plasma, is a groundbreaking development in equine health care.
What is eACTH and Why is it Important?
ACTH is a hormone that plays a crucial role in regulating the body’s response to stress and metabolism. In horses, elevated levels of eACTH can indicate conditions such as Cushing’s disease, a common endocrine disorder in older horses. The ability to measure eACTH levels directly at the point of care with the TRUFORMA biosensor platform is a game-changer for equine veterinarians, allowing for quicker and more accurate diagnosis and treatment of such conditions.
Zomedica’s commitment to redefining what is possible in point of care diagnostics is evident in their continuous innovation and dedication to improving the health and well-being of animals. With the TRUFORMA biosensor platform, they are leading the way in bringing cutting-edge technology to the world of veterinary medicine.
How Will This Impact Me?
If you’re a horse owner, the availability of the TRUFORMA biosensor platform with the eACTH assay could mean quicker and more accurate diagnosis of health issues in your equine companions. This can lead to earlier intervention and better outcomes for your horses.
How Will This Impact the World?
Zomedica’s advancements in point-of-care diagnostics have the potential to revolutionize the way veterinary medicine is practiced around the world. By enabling veterinarians to quickly and accurately diagnose and treat conditions in animals, the TRUFORMA biosensor platform could improve the overall health and well-being of countless animals.
Conclusion
Zomedica’s TRUFORMA biosensor platform is truly changing the game in equine health care. With their latest update to the eACTH assay, they are redefining what is possible in point of care diagnostics and setting a new standard for veterinary medicine. The impact of their innovation can be felt not only by individual horse owners, but also by the world at large as they pave the way for a brighter future in animal health.
